|
US5077044A
(en)
|
1980-05-19 |
1991-12-31 |
The Board Of Trustees Of The Leland Stanford Jr. University |
Novel non-reverting shigella live vaccines
|
|
US4722848A
(en)
|
1982-12-08 |
1988-02-02 |
Health Research, Incorporated |
Method for immunizing animals with synthetically modified vaccinia virus
|
|
US5338683A
(en)
|
1981-12-24 |
1994-08-16 |
Health Research Incorporated |
Vaccinia virus containing DNA sequences encoding herpesvirus glycoproteins
|
|
US5110587A
(en)
|
1981-12-24 |
1992-05-05 |
Health Research, Incorporated |
Immunogenic composition comprising synthetically modified vaccinia virus
|
|
US5174993A
(en)
|
1981-12-24 |
1992-12-29 |
Health Research Inc. |
Recombinant avipox virus and immunological use thereof
|
|
US5036006A
(en)
|
1984-11-13 |
1991-07-30 |
Cornell Research Foundation, Inc. |
Method for transporting substances into living cells and tissues and apparatus therefor
|
|
US4945050A
(en)
|
1984-11-13 |
1990-07-31 |
Cornell Research Foundation, Inc. |
Method for transporting substances into living cells and tissues and apparatus therefor
|
|
GB8508845D0
(en)
|
1985-04-04 |
1985-05-09 |
Hoffmann La Roche |
Vaccinia dna
|
|
US5223424A
(en)
|
1985-09-06 |
1993-06-29 |
Prutech Research And Development |
Attenuated herpesviruses and herpesviruses which include foreign DNA encoding an amino acid sequence
|
|
US5310668A
(en)
|
1986-06-20 |
1994-05-10 |
Merck & Co., Inc. |
Varicella-zoster virus as a live recombinant vaccine
|
|
US5242829A
(en)
|
1986-09-23 |
1993-09-07 |
Therion Biologics Corporation |
Recombinant pseudorabies virus
|
|
IL86583A0
(en)
|
1987-06-04 |
1988-11-15 |
Molecular Eng Ass |
Vaccine containing a derivative of a microbe and method for the production thereof
|
|
US5387744A
(en)
|
1987-06-04 |
1995-02-07 |
Washington University |
Avirulent microbes and uses therefor: Salmonella typhi
|
|
US5294441A
(en)
|
1987-06-04 |
1994-03-15 |
Washington University |
Avirulent microbes and uses therefor: salmonella typhi
|
|
US5112749A
(en)
|
1987-10-02 |
1992-05-12 |
Praxis Biologics, Inc. |
Vaccines for the malaria circumsporozoite protein
|
|
US5225336A
(en)
|
1989-03-08 |
1993-07-06 |
Health Research Incorporated |
Recombinant poxvirus host range selection system
|
|
JP3044062B2
(ja)
|
1989-03-08 |
2000-05-22 |
ヘルス・リサーチ・インク |
組換えポックスウイルス宿主選択系
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
EP0465560B1
(en)
|
1989-03-31 |
1996-06-05 |
Washington University |
VACCINES CONTAINING AVIRULENT phoP-TYPE MICROORGANISMS
|
|
EP0431668B1
(en)
|
1989-12-04 |
1995-02-15 |
Akzo Nobel N.V. |
Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
|
|
US5294548A
(en)
|
1990-04-02 |
1994-03-15 |
American Biogenetic Sciences, Inc |
Recombianant Hepatitis a virus
|
|
US5462734A
(en)
|
1990-11-02 |
1995-10-31 |
Wisconsin Alumni Research Foundation |
Bovine herpesvirus vaccine and method of using same
|
|
US5240703A
(en)
|
1991-03-01 |
1993-08-31 |
Syntro Corporation |
Attenuated, genetically-engineered pseudorabies virus s-prv-155 and uses thereof
|
|
CA2087132A1
(en)
|
1992-01-31 |
1993-08-01 |
Michael S. Williams |
Stent capable of attachment within a body lumen
|
|
US5273525A
(en)
|
1992-08-13 |
1993-12-28 |
Btx Inc. |
Injection and electroporation apparatus for drug and gene delivery
|
|
US5593972A
(en)
|
1993-01-26 |
1997-01-14 |
The Wistar Institute |
Genetic immunization
|
|
US5981505A
(en)
|
1993-01-26 |
1999-11-09 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for delivery of genetic material
|
|
US5439440A
(en)
|
1993-04-01 |
1995-08-08 |
Genetronics, Inc. |
Electroporation system with voltage control feedback for clinical applications
|
|
US5993434A
(en)
|
1993-04-01 |
1999-11-30 |
Genetronics, Inc. |
Method of treatment using electroporation mediated delivery of drugs and genes
|
|
US5702359A
(en)
|
1995-06-06 |
1997-12-30 |
Genetronics, Inc. |
Needle electrodes for mediated delivery of drugs and genes
|
|
US5739118A
(en)
|
1994-04-01 |
1998-04-14 |
Apollon, Inc. |
Compositions and methods for delivery of genetic material
|
|
NL9401820A
(nl)
|
1994-11-02 |
1996-06-03 |
Meyn Maschf |
Inrichting voor het bewerken van aan zijn poten opgehangen gevogelte.
|
|
US5962428A
(en)
|
1995-03-30 |
1999-10-05 |
Apollon, Inc. |
Compositions and methods for delivery of genetic material
|
|
US5810762A
(en)
|
1995-04-10 |
1998-09-22 |
Genetronics, Inc. |
Electroporation system with voltage control feedback for clinical applications
|
|
KR100780158B1
(ko)
|
1996-10-23 |
2007-11-27 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
면역 치료법 및 개량 백신
|
|
JP2001520537A
(ja)
|
1997-04-03 |
2001-10-30 |
エレクトロフェクト・アクティーゼルスカブ |
医薬品と核酸の骨格筋への導入方法
|
|
US6261281B1
(en)
|
1997-04-03 |
2001-07-17 |
Electrofect As |
Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
|
|
HUP0004589A3
(en)
|
1997-06-30 |
2003-08-28 |
Centre Nat Rech Scient |
Improved method for transferring nucleic acid into the striped muscle and combination therefor
|
|
US6055453A
(en)
|
1997-08-01 |
2000-04-25 |
Genetronics, Inc. |
Apparatus for addressing needle array electrodes for electroporation therapy
|
|
US6241701B1
(en)
|
1997-08-01 |
2001-06-05 |
Genetronics, Inc. |
Apparatus for electroporation mediated delivery of drugs and genes
|
|
US6216034B1
(en)
|
1997-08-01 |
2001-04-10 |
Genetronics, Inc. |
Method of programming an array of needle electrodes for electroporation therapy of tissue
|
|
US6135990A
(en)
|
1997-12-17 |
2000-10-24 |
University Of South Florida |
Electroporation device and method
|
|
US6778853B1
(en)
|
1997-12-17 |
2004-08-17 |
University Of South Florida |
Electroporation device
|
|
US6120493A
(en)
|
1998-01-27 |
2000-09-19 |
Genetronics, Inc. |
Method for the introduction of therapeutic agents utilizing an electroporation apparatus
|
|
AU3973599A
(en)
|
1998-05-08 |
1999-11-29 |
Genetronics, Inc. |
Electrically induced vessel vasodilation
|
|
US20050037018A1
(en)
*
|
2003-06-20 |
2005-02-17 |
Innogentics N.V. |
HCV combination therapy
|
|
US6678556B1
(en)
|
1998-07-13 |
2004-01-13 |
Genetronics, Inc. |
Electrical field therapy with reduced histopathological change in muscle
|
|
EP1100579B1
(en)
|
1998-07-13 |
2015-09-02 |
Inovio Pharmaceuticals, Inc. |
Skin and muscle-targeted gene therapy by pulsed electrical field
|
|
BR0008645A
(pt)
|
1999-03-03 |
2002-01-22 |
Univ Pennsylvania |
Métodos de induzir uma resposta imunológica contra um imunógeno em um indivìduo, de reduzir rejeição de células, tecido ou órgão doadores nã0-assemelhados em um indivìduo e uma resposta imunológica dominante em um indivìduo e de expandir uma subpopulação de células t associadas com uma resposta imunológica especìfica, plasmìdeo, e, composição
|
|
MXPA02011191A
(es)
|
2000-05-12 |
2003-07-28 |
Univ Pennsylvania |
Vacunas, inmunoterapeuticos, y metodos de uso de los mismos.
|
|
US20020155127A1
(en)
|
2000-06-02 |
2002-10-24 |
Danher Wang |
Genetic vaccine against human immunodeficiency virus
|
|
US6927040B2
(en)
|
2000-06-30 |
2005-08-09 |
Zymogenetics, Inc. |
Interferon-like protein Zcyto21
|
|
US7038032B2
(en)
|
2001-04-20 |
2006-05-02 |
Zymogenetics, Inc. |
Cytokine protein family
|
|
US7245963B2
(en)
|
2002-03-07 |
2007-07-17 |
Advisys, Inc. |
Electrode assembly for constant-current electroporation and use
|
|
US8209006B2
(en)
|
2002-03-07 |
2012-06-26 |
Vgx Pharmaceuticals, Inc. |
Constant current electroporation device and methods of use
|
|
EP1575609A4
(en)
*
|
2002-10-23 |
2010-12-15 |
Zymogenetics L L C |
METHOD FOR THE TREATMENT OF VIRUS INFECTIONS USING IL-28 AND IL-29
|
|
NZ570709A
(en)
|
2003-06-13 |
2010-04-30 |
Univ Pennsylvania |
Nucleic acid sequences encoding and compositions comprising IgE signal peptide and/or IL-15 and methods for using the same
|
|
US8008265B2
(en)
|
2003-06-13 |
2011-08-30 |
The Trustees Of The University Of Pennsylvania |
Vaccines, immunotherapeutics and methods for using the same
|
|
EP1927600A1
(en)
|
2003-08-07 |
2008-06-04 |
Zymogenetics, Inc. |
Homogeneous preparations of IL-28 and IL-29
|
|
US20070166784A1
(en)
*
|
2003-09-15 |
2007-07-19 |
Barnett Susan W |
Combination approaches for generating immune responses
|
|
WO2005097165A2
(en)
*
|
2004-04-02 |
2005-10-20 |
Zymogenetics, Inc. |
Il-28 and il-29 cysteine mutants for treating viral infection
|
|
CN101031316A
(zh)
|
2004-07-29 |
2007-09-05 |
津莫吉尼蒂克斯公司 |
Il－28和il－29治疗癌症和自身免疫性疾病的用途
|
|
CA2574564C
(en)
|
2004-07-29 |
2013-04-16 |
Zymogenetics, Inc. |
Use of il-28 and il-29 to treat cancer and autoimmune disorders
|
|
WO2006063301A1
(en)
*
|
2004-12-10 |
2006-06-15 |
Maxcyte, Inc. |
Genetically modified tumor cells as cancer vaccines
|
|
CA2593648A1
(en)
|
2005-01-10 |
2006-07-13 |
Research Development Foundation |
Targeted chimeric molecules for cancer therapy
|
|
JP2008528508A
(ja)
|
2005-01-21 |
2008-07-31 |
イントロジェン・セラピューティクス，インコーポレイテッド |
標的細胞の治療および予防核酸への持続性の曝露を可能とする局所投与
|
|
AU2006265002B2
(en)
|
2005-06-30 |
2012-09-20 |
Centocor, Inc. |
Anti-IL-23 antibodies, compositions, methods and uses
|
|
ES2993941T3
(en)
|
2006-10-17 |
2025-01-14 |
Inovio Pharmaceuticals Inc |
Electroporation devices for electroporation of cells in mammals
|
|
NZ583783A
(en)
*
|
2007-09-20 |
2012-10-26 |
Commw Scient Ind Res Org |
Avian interferon-lambda polypeptide and genetic sequences encoding the same
|